OH2 Injection in Solid Tumors

Clinical trial NCT04386967 · COMPLETED

Trial details

NCT number: NCT04386967
Sponsor: Binhui Biopharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Solid Tumor Melanoma

Start date: 2018-11-22
Primary completion: 2026-06-02
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.